Weekly digest -March 02 2022
|
Q&A
GERALD LEONG OF SYLVAN GROUP
Gerald Leong, a 25-year veteran of Asian private equity, believes returns-focused impact investment is the future of the industry. His new firm, Singapore-based Sylvan Group, will attempt to prove it.ANALYSIS
AUSTRALIA VC: AN IDEAL MATCH?
Having backed Australian VCs for Hostplus, Neil Stanford is now raising a fund-of-funds with a view to catalysing a state-wide start-up ecosystem. A preferred return structure is being used to lure LPs.DEAL FOCUS
ADV'S ASIA HYGIENE PLATFORM PLAY
ISS Environmental Services is well-positioned as Hong Kong's preferred provider of portable toilets. But ADV Partners has acquired the business with a view to executing a regional roll-up strategy.DEAL FOCUS
QUADRIA GOES SHOPPING IN VIETNAM
Singapore's healthcare-focused Quadria Capital has made its most overtly consumer retail-oriented investment with Vietnam's Con Cung. But the endgame is considered squarely on-strategy.DEAL FOCUS
AFFIRMA SEES PROMISE IN ASIA E-SCOOTERS
Affirma Capital has led a USD 93m Series B round for Singapore-based e-scooter provider Beam, citing its ability to internationalise a locally-focused and increasingly popular business model. |
|
AVCJ AWARDS 2021
EXIT OF THE YEAR - SMALL CAP: INTEGREON
Helping Integreon re-focus and renew management was all part of the plan; delaying the exit as COVID-19 amplifed demand was the unexpected coup. NewQuest Capital Partners also received the Operational Value Add Award for its work.AVCJ AWARDS 2021
FUNDRAISING OF THE YEAR - LARGE CAP: KKR
Working around travel restrictions and reaching into the high-net-worth segment were key themes as KKR raised USD 15bn for its fourth pan-Asia fund, the largest vehicle of its kind to date.AVCJ AWARDS 2021
EXIT OF THE YEAR - IPO: ZOMATO
For Centurium Capital, China Biologic was no ordinary take-private. It was the culmination of a multi-year effort to tighten the company's shareholding structure and root out management inefficiencies. |
|
For your calendar
UPCOMING EVENTS
|
Latest News
Asian GPs slow implementation of ESG policies - survey
Asia-based private equity firms are assigning more dedicated resources to environment, social, and governance (ESG) programmes, but policy changes have slowed in the past 12 months, in part due to concerns raised internally and by LPs, according to a...
Singapore fintech start-up LXA gets $10m seed round
New Enterprise Associates (NEA) has led a USD 10m seed round for Singapore’s LXA, a financial technology start-up launched by a former Asia senior executive at The Blackstone Group.
India's InCred announces $60m round, claims unicorn status
Indian non-bank lender InCred Financial Services said it has received INR 5bn (USD 60m) at a valuation of at least USD 1bn from unnamed investors including “a global private equity fund.”
Insight leads $50m round for Australia's Roller
Insight Partners has led a USD 50m round for Australia’s Roller, a venue management software provider specializing in family fun parks.


Gerald Leong, a 25-year veteran of Asian private equity, believes returns-focused impact investment is the future of the industry. His new firm, Singapore-based Sylvan Group, will attempt to prove it.
Having backed Australian VCs for Hostplus, Neil Stanford is now raising a fund-of-funds with a view to catalysing a state-wide start-up ecosystem. A preferred return structure is being used to lure LPs.
ISS Environmental Services is well-positioned as Hong Kong's preferred provider of portable toilets. But ADV Partners has acquired the business with a view to executing a regional roll-up strategy.
Singapore's healthcare-focused Quadria Capital has made its most overtly consumer retail-oriented investment with Vietnam's Con Cung. But the endgame is considered squarely on-strategy.
Affirma Capital has led a USD 93m Series B round for Singapore-based e-scooter provider Beam, citing its ability to internationalise a locally-focused and increasingly popular business model.
Helping Integreon re-focus and renew management was all part of the plan; delaying the exit as COVID-19 amplifed demand was the unexpected coup. NewQuest Capital Partners also received the Operational Value Add Award for its work.
Working around travel restrictions and reaching into the high-net-worth segment were key themes as KKR raised USD 15bn for its fourth pan-Asia fund, the largest vehicle of its kind to date.
For Centurium Capital, China Biologic was no ordinary take-private. It was the culmination of a multi-year effort to tighten the company's shareholding structure and root out management inefficiencies.






